La lecture en ligne est gratuite
Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres
Télécharger Lire

IDEV Technologies Strengthens Commercial Leadership

2 pages

IDEV Technologies Strengthens Commercial Leadership PR Newswire WEBSTER, Texas, June 6, 2012 WEBSTER, Texas, June 6, 2012 /PRNewswire/ -- IDEV Technologies, Inc.

Ajouté le : 26 juin 2012
Lecture(s) : 0
Signaler un abus

Vous aimerez aussi

IDEV Technologies Strengthens Commercial
Leadership
PR Newswire
WEBSTER, Texas, June 6, 2012
WEBSTER, Texas
,
June 6, 2012
/PRNewswire/ -- IDEV Technologies, Inc. (IDEV),
an emerging innovator in peripheral vascular devices, announced the hiring of
Trent Reutiman as Vice President, Global Commercial Operations. He joins the
company after successful sales and marketing positions at ROX Medical and
several other start-ups. His early career was in sales and sales management at
Guidant and Cordis.
In addition to Reutiman, IDEV has further supplemented the global team with
additional hires in key areas including the commercial organization, product
development, and operations as the company continues to develop its business
through organic growth, new product launches, and geographic expansion.
"The addition of Trent to our senior management team is a reflection of our
commitment to further expand our capabilities, and to execute our long term
strategy," commented Christopher Owens, President and CEO of IDEV. "All the
new resources bring global experience that further enhances our existing
organization as we work to develop and complement our unique technology
platform."
Reutiman, in this newly created role, will lead the global sales and marketing
teams as the company continues to expand distribution and sales of its flagship
product, the SUPERA® stent.
"I'm excited to join IDEV at this time," commented Reutiman. "With recent
product launches in multiple countries in the
Asia Pacific
region, continued
market penetration in
Europe
, and intense preparations for the anticipated FDA
approval of the SUPERA stent in the U.S., we are setting strategies that are vital
to successful commercial execution."
About IDEV Technologies, Incorporated
IDEV Technologies, Incorporated (IDEV) is an innovator and developer of next
generation medical devices for use in interventional radiology, vascular surgery
and cardiology. IDEV's worldwide headquarters is located in
Webster, Texas
and its European headquarters is located in Beuningen,
The Netherlands
.
The SUPERA stent is currently indicated in
the United States
for the palliative
treatment of biliary strictures produced by malignant neoplasms and in multiple
other countries for the treatment of biliary strictures produced by malignant
neoplasms and for peripheral vascular use following failed percutaneous
transluminal angioplasty (PTA).
For more information please visit www.idevmd.com.
Contact:
Donna Lucchesi
Vice President Global Marketing
IDEV Technologies, Incorporated
+1-281-525-2000
Un pour Un
Permettre à tous d'accéder à la lecture
Pour chaque accès à la bibliothèque, YouScribe donne un accès à une personne dans le besoin